Literature DB >> 19809284

Age-dependent bupivacaine-induced muscle toxicity during continuous peripheral nerve block in rats.

Karine Nouette-Gaulain1, Christophe Dadure, Didier Morau, Claire Pertuiset, Olivier Galbes, Maurice Hayot, Jacques Mercier, François Sztark, Rodrigue Rossignol, Xavier Capdevila.   

Abstract

BACKGROUND: Regional blocks improve postoperative analgesia and postoperative rehabilitation in children and adult patients. Continuous peripheral nerve blocks have been proposed as safe and effective techniques for postoperative pain relief and chronic pain therapy, particularly in small children. Few clinical reports have described myotoxicity induced by bupivacaine in these young patients, in contrast with a larger number of observations in adults. Here, the authors addressed this issue by a comparative evaluation of bupivacaine-induced myotoxicity in young versus adult rats.
METHODS: Femoral nerve block catheters were inserted in male Wistar rats. Young (3-week-old) and adult (12-week-old) rats were randomly assigned to received seven injections (1 ml/kg) of 0.25% bupivacaine (n = 6 per experiment) or isotonic saline (n = 6 per experiment) at 8-h intervals. Rats were killed 8 h after the last injection. Psoas muscle adjacent to the femoral nerve was quickly dissected. Oxygen consumption rates were measured in saponin-skinned fibers, mitochondrial adenosine triphosphate synthesis rates were determined by bioluminescence, and citrate synthase activity was determined by spectrophotometry. Muscle ultrastructural damage was also examined and scored as normal, focal disruption, moderate disruption, or extreme disruption of the sarcomeres.
RESULTS: Bupivacaine caused a reduction of mitochondrial adenosine triphosphate synthesis rate, a decrease of citrate synthase activity, and muscle ultrastructural damages. Young rats treated with bupivacaine showed more severe alterations of mitochondrial bioenergetics and muscle ultrastructure.
CONCLUSIONS: These findings demonstrate that bupivacaine-induced myotoxicity can be explained by mitochondrial bioenergetics alterations, which are more severe in young rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19809284     DOI: 10.1097/ALN.0b013e3181bbc949

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

1.  Rotator cuff healing after continuous subacromial bupivacaine infusion: an in vivo rabbit study.

Authors:  Nicole A Friel; Vincent M Wang; Mark A Slabaugh; FanChia Wang; Susan Chubinskaya; Brian J Cole
Journal:  J Shoulder Elbow Surg       Date:  2012-07-20       Impact factor: 3.019

2.  Bupivacaine, ropivacaine, and morphine: comparison of toxicity on human hamstring-derived stem/progenitor cells.

Authors:  Florian Haasters; Hans Polzer; Wolf Christian Prall; Maximilian Michael Saller; Julia Kohler; Stefan Grote; Wolf Mutschler; Denitsa Docheva; Matthias Schieker
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-06-07       Impact factor: 4.342

3.  New formulations of local anaesthetics-part I.

Authors:  Edward A Shipton
Journal:  Anesthesiol Res Pract       Date:  2011-12-05

Review 4.  Drug Repurposing: The Mechanisms and Signaling Pathways of Anti-Cancer Effects of Anesthetics.

Authors:  King-Chuen Wu; Kai-Sheng Liao; Li-Ren Yeh; Yang-Kao Wang
Journal:  Biomedicines       Date:  2022-07-04

Review 5.  Liposomal extended-release bupivacaine for postsurgical analgesia.

Authors:  Mark Lambrechts; Michael J O'Brien; Felix H Savoie; Zongbing You
Journal:  Patient Prefer Adherence       Date:  2013-09-06       Impact factor: 2.711

6.  Redox mechanism of levobupivacaine cytostatic effect on human prostate cancer cells.

Authors:  Caroline Jose; Etienne Hebert-Chatelain; Nivea Dias Amoedo; Emmanuel Roche; Emilie Obre; Didier Lacombe; Hamid Reza Rezvani; Philippe Pourquier; Karine Nouette-Gaulain; Rodrigue Rossignol
Journal:  Redox Biol       Date:  2018-05-31       Impact factor: 11.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.